[1]
|
Zou, Y., Zhao, X., Li, Y. and Duan, S.W. (2020) MiR-552: An Important Post-Transcriptional Regulator That Affects Human Cancer. Journal of Cancer, 11, 6226-6233. https://doi.org/10.7150/jca.46613
|
[2]
|
Deldar Abad Paskeh, M., Mirzaei, S., Orouei, S., et al. (2021) Revealing the Role of MiRNA-489 as a New Onco-Suppressor Factor in Different Cancers Based on Pre-Clinical and Clinical Evidence. International Journal of Biological Macromolecules, 191, 727-737. https://doi.org/10.1016/j.ijbiomac.2021.09.089
|
[3]
|
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., et al. (2021) Lung Cancer Cells and Their Sensitivity/Resistance to Cisplatin Chemotherapy: Role of MicroRNAs and Upstream Me-diators. Cellular Signalling, 78, Article ID: 109871.
https://doi.org/10.1016/j.cellsig.2020.109871
|
[4]
|
Mattiske, S., Suetani, R.J., Neilsen, P.M. and Callen, D.F. (2021) The Oncogenic Role of MiR-155 in Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 21, 1236-1243. https://doi.org/10.1158/1055-9965.EPI-12-0173
|
[5]
|
Krek, A., Grün, D., Poy, M.N., et al. (2005) Combinatorial MicroRNA Target Predictions. Nature Genetics, 37, 495-500.
https://doi.org/10.1038/ng1536
|
[6]
|
Zou, Y., Zhao, X., Li, Y., et al. (2021) MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. Frontiers in Oncology, 11, Article ID: 743701.
|
[7]
|
Favero, A., Segatto, I., Perin, T. and Belletti, B. (2021) The Many Facets of MiR-223 in Cancer: Oncosuppressor, Oncogenic Driver, Therapeu-tic Target, and Biomarker of Response. WIREs RNA, 12, e1659.
https://doi.org/10.1002/wrna.1659
|
[8]
|
Cavallari, I., Ciccarese, F., Sharova, E., et al. (2021) The MiR-200 Family of MicroRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers, 13, Ar-ticle 5874.
https://doi.org/10.3390/cancers13235874
|
[9]
|
Hong, L., Han, Y., Zhang, H., et al. (2013) MiR-210: A Therapeutic Target in Cancer. Expert Opinion on Therapeutic Targets, 17, 21-28. https://doi.org/10.1517/14728222.2012.732066
|
[10]
|
Pan, Y.J., Zhuang, Y., Zheng, J.N. and Pei, D.S. (2016) MiR-106a: Promising Biomarker for Cancer. Bioorganic & Medicinal Chemistry Letters, 26, 5373-5377. https://doi.org/10.1016/j.bmcl.2016.10.042
|
[11]
|
Hermyt, E., Zmarzly, N., KruszniewskaRajs, C., et al. (2023) Ex-pression Pattern of Circadian Rhythm-Related Genes and Its Potential Relationship with MiRNAs Activity in Endometri-al Cancer. Ginekologia Polska, 94, 33-40.
https://doi.org/10.5603/GP.a2022.0063
|
[12]
|
Han, Y., Qian, X., Xu, T. and Shi, Y. (2022) Carcinoma-Associated Fibroblasts Release MicroRNA-331-3p Containing Extracellular Vesicles to Exacerbate the Development of Pancreatic Cancer via the SCARA5-FAK Axis. Cancer Biology & Therapy, 23, 378-392. https://doi.org/10.1080/15384047.2022.2041961
|
[13]
|
Zheng, L., Li, M., Gu, R., et al. (2022) Prediction of Necroptosis-Related Markers in Head and Neck Carcinoma by Bioinformatics. Journal of Immunology Research, 2022, Article ID: 1993023. https://doi.org/10.1155/2022/1993023
|
[14]
|
Bi, W., Yang, M., Xing, P., et al. (2022) Mi-croRNA MiR-331-3p Suppresses Osteosarcoma Progression via the Bcl-2/ Bax and Wnt/β-Catenin Signaling Pathways and the Epithelial-Mesenchymal Transition by Targeting N-Acetylgluco- saminyltransferase I (MGAT1). Bioengineered, 13, 14159-14174. https://doi.org/10.1080/21655979.2022.2083855
|
[15]
|
Yao, B., Zhu, S., Wei, X., et al. (2022) The CircSPON2/MiR-331-3p Axis Regulates PRMT5, An Epigenetic Regulator of CAMK2N1 Transcription and Pros-tate Cancer Progression. Molecular Cancer, 21, Article No. 119.
https://doi.org/10.1186/s12943-022-01598-6
|
[16]
|
Ma, H., Shen, L., Yang, H., et al. (2022) Circular RNA CircPSAP Functions as an Efficient MiR-331-3p Sponge to Regulate Proliferation, Apoptosis and Bortezomib Sensitivi-ty of Human Multiple Myeloma Cells by Upregulating HDAC4. Journal of Pharmacological Sciences, 149, 27-36. https://doi.org/10.1016/j.jphs.2022.01.013
|
[17]
|
Zheng, L., Wang, J., Jiang, H., et al. (2022) A Novel Necropto-sis-Related MiRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis. Disease Markers, 2022, Article ID: 3391878. https://doi.org/10.1155/2022/3391878
|
[18]
|
Li, J.L., Liu, X.L., Guo, S.F., Yang, Y., Zhu, Y.L. and Li, J.Z. (2019) Long Noncoding RNA UCA1 Regulates Proliferation and Apoptosis in Multiple Myeloma by Targeting MiR-331-3p/IL6R Axis for the Activation of JAK2/STAT3 Pathway. European Review for Medical and Pharmacologi-cal Sciences, 23, 9238-9250.
|
[19]
|
Zhou, X., Jiang, J. and Guo, S. (2021) Hsa_Circ_0004712 Downregulation Attenu-ates Ovarian Cancer Malignant Development by Targeting the MiR-331-3p/FZD4 Pathway. Journal of Ovarian Re-search, 14, Article No. 118.
https://doi.org/10.1186/s13048-021-00859-0
|
[20]
|
Sui, Y.X., Zhao, D.L., Yu, Y. and Wang, L.C. (2021) The Role, Function, and Mechanism of Long Intergenic Noncoding RNA1184 (Linc01184) in Colorectal Cancer. Disease Markers, 2021, Article ID: 8897906.
https://doi.org/10.1155/2021/8897906
|
[21]
|
Chi, Q., Geng, X., Xu, K., et al. (2020) Potential Targets and Molecular Mechanism of MiR-331-3p in Hepatocellular Carcinoma Identified by Weighted Gene Coexpression Network Analysis. Bioscience Reports, 40, BSR20200124.
https://doi.org/10.1042/BSR20200124
|
[22]
|
Chen, X., Luo, H., Li, X., et al. (2018) MiR-331-3p Functions as an Oncogene by Targeting ST7L in Pancreatic Cancer. Carcinogenesis, 39, 1006-1015. https://doi.org/10.1093/carcin/bgy074
|
[23]
|
Zhan, T., Chen, X., Tian, X., et al. (2020) MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L. Technology in Cancer Research & Treatment, 19, 1-8.
https://doi.org/10.1177/1533033820945801
|
[24]
|
Zhao, M., Zhang, M., Tao, Z., et al. (2020) MiR-331-3p Sup-presses Cell Proliferation in TNBC Cells by Downregulating NRP2. Technology in Cancer Research & Treatment, 19, 1-9. https://doi.org/10.1177/1533033820905824
|
[25]
|
Jiang, C., Shi, X., Yi, D., et al. (2021) Long Non-Coding RNA Anti-Differentiation Non-Coding RNA Affects Proliferation, Invasion, and Migration of Breast Cancer Cells by Targeting MiR-331. Bioengineered, 12, 12236-12245.
https://doi.org/10.1080/21655979.2021.2005989
|
[26]
|
Jin, W., Zhong, N., Wang, L., et al. (2019) MiR-331-3p In-hibition of the Hepatocellular Carcinoma (HCC) Bel-7402 Cell Line by Down-Regulation of E2F1. Journal of Nanosci-ence and Nanotechnology, 19, 5476-5482.
https://doi.org/10.1166/jnn.2019.16535
|
[27]
|
Li, X., Zhu, J., Liu, Y., et al. (2019) MicroRNA-331-3p Inhibits Epi-thelial-Mesenchymal Transition by Targeting ErbB2 and VAV2 Through the Rac1/PAK1/β-Catenin Axis in Non-Small-Cell Lung Cancer. Cancer Science, 110, 1883-1896. https://doi.org/10.1111/cas.14014
|
[28]
|
Zhang, L., Song, X., Chen, X., et al. (2019) Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression. International Journal of Biological Sciences, 15, 1091- 1103. https://doi.org/10.7150/ijbs.31533
|
[29]
|
Chen, H., Zong, J. and Wang, S. (2019) LncRNA GAPLINC Promotes the Growth and Metastasis of Glioblastoma by Sponging MiR-331-3p. European Review for Medical and Pharmacological Sciences, 23, 262-270.
|
[30]
|
Luan, X. and Wang, Y. (2018) LncRNA XLOC_006390 Facilitates Cervical Cancer Tu-morigenesis and Metastasis as a CeRNA against MiR-331-3p and MiR-338-3p. Journal of Gynecologic Oncology, 29, e95.
https://doi.org/10.3802/jgo.2018.29.e95
|
[31]
|
Liu, T., Song, Z. and Gai, Y. (2019) Circular RNA Circ_0001649 Acts as a Prognostic Biomarker and Inhibits NSCLC Progression via Sponging MiR-331-3p and MiR-338-5p. Bio-chemical and Biophysical Research Communications, 503, 1503-1509. https://doi.org/10.1016/j.bbrc.2018.07.070
|
[32]
|
Zmarzły, N., Hermyt, E., KruszniewskaRajs, C., et al. (2021) Ex-pression Profile of EMT-Related Genes and MiRNAs Involved in Signal Transduction via the Wnt Pathway and Cad-herins in Endometrial Cancer. Current Pharmaceutical Biotechnology, 22, 1663-1671. https://doi.org/10.2174/1389201021666201218125900
|
[33]
|
Papadopoulos, E.I., Papachristopoulou, G., Ardavanis, A., et al. (2018) A Comprehensive Clinicopathological Evaluation of the Differential Expression of MicroRNA-331 in Breast Tumors and Its Diagnostic Significance. Clinical Biochemistry, 60, 24-32. https://doi.org/10.1016/j.clinbiochem.2018.07.008
|
[34]
|
Jiang, F., Zhang, L., Liu, Y., et al. (2020) Overexpression of MiR-331 Indicates Poor Prognosis and Promotes Progression of Breast Cancer. Oncology Research and Treatment, 43, 441-448. https://doi.org/10.1159/000508792
|
[35]
|
Wijayakumara, D.D., et al. (2018) Regulation of UDP-Glucuronosyltransferase 2B15 by MiR-331-5p in Prostate Cancer Cells Involves Canonical and Noncanonical Target Sites. Journal of Pharmacology and Experimental Therapeutics, 365, 48-59. https://doi.org/10.1124/jpet.117.245936
|
[36]
|
Li, J., Jin, B., Wang, T., et al. (2019) Serum MicroRNA Expression Profiling Identifies Serum Biomarkers for HCV- Related Hepatocellular Carcinoma. Cancer Biomarkers, 26, 501-512. https://doi.org/10.3233/CBM-181970
|
[37]
|
Chen, W., Quan, Y., Fan, S., et al. (2020) Exosome-Transmitted Circu-lar RNA Hsa_Circ_0051443 Suppresses Hepatocellular Carcinoma Progression. Cancer Letters, 475, 119-128. https://doi.org/10.1016/j.canlet.2020.01.022
|
[38]
|
Sun, Q., Li, J., Jin, B., et al. (2020) Evaluation of MiR-331-3p and MiR-23b-3p as Serum Biomarkers for Hepatitis C Virus-Related Hepatocellular Carcinoma at Early Stage. Clinics and Research in Hepatology and Gastroenterology, 44, 21-28. https://doi.org/10.1016/j.clinre.2019.03.011
|
[39]
|
Li, S., Zhao, J., Wen, S., et al. (2023) CircRNA High Mobility Group At-Hook 2 Regulates Cell Proliferation, Metastasis and Glycolytic Metabolism of Nonsmall Cell Lung Cancer by Targeting MiR-331-3p to Upregulate High Mobility Group at-Hook 2. Anticancer Drugs, 34, 81-91. https://doi.org/10.1097/CAD.0000000000001343
|
[40]
|
Zhang, M., Song, Y. and Zhai, F. (2018) ARFHPV E7 Oncogene, LncRNA HOTAIR, MiR-331-3p and Its Target, NRP2, form a Nega-tive Feedback Loop to Regulate the Apoptosis in the Tumorigenesis in HPV Positive Cervical Cancer. Journal of Cellu-lar Biochemistry, 119, 4397-4407. https://doi.org/10.1002/jcb.26503
|
[41]
|
Yang, S., Wang, L., Gu, L., et al. (2022) Mesenchymal Stem Cell-Derived Extracellular Vesicles Alleviate Cervical Cancer by Delivering MicroRNA-331-3p to Reduce LIM Zinc Finger Domain Containing 2 Methylation in Tumor Cells. Human Molecular Genetics, 31, 3829-3845. https://doi.org/10.1093/hmg/ddac130
|
[42]
|
Feng, J., Li, J., Wu, L., et al. (2020) Emerging Roles and the Regulation of Aerobic Glycolysis in Hepatocellular Carcinoma. Journal of Experimental & Clinical Cancer Research, 39, Article No. 126.
https://doi.org/10.1186/s13046-020-01629-4
|
[43]
|
Zheng, X., Liu, R., Zhou, C., et al. (2021) ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacteriumnucleatum in Colorectal Cancer. Cancer Research, 81, 6157-6170.
https://doi.org/10.1158/0008-5472.CAN-21-2273
|
[44]
|
Xie, M., Fu, X.G. and Jiang, K. (2021) Notch1/TAZ Axis Promotes Aerobic Glycolysis and Immune Escape in Lung Cancer. Cell Death & Disease, 12, Article No. 832. https://doi.org/10.1038/s41419-021-04124-6
|
[45]
|
Wu, Q., Zhang, W., Liu, Y., et al. (2021) Histone Deacetylase 1 Facilitates Aerobic Glycolysis and Growth of Endometrial Cancer. Oncology Letters, 22, Article No. 721. https://doi.org/10.3892/ol.2021.12982
|
[46]
|
Li, X.M., Jiao, Y.Y., Luan, B.H., et al. (2020) Long Non-Coding RNA MIAT Promotes Gastric Cancer Proliferation and Metastasis via Modulating the MiR-331-3p/RAB5B Pathway. Oncol-ogy Letters, 20, Article No. 355.
https://doi.org/10.3892/ol.2020.12219
|
[47]
|
Fujii, T., Shimada, K., Tatsumi, Y., et al. (2016) Syndecan-1 Up-Regulates MicroRNA-331-3p and Mediates Epithelial-to-Mesenchymal Transition in Prostate Cancer. Molecular Carcinogenesis, 55, 1378-1386.
https://doi.org/10.1002/mc.22381
|
[48]
|
Hu, M. and Yang, J. (2020) Down-Regulation of LncRNA UCA1 Enhanc-es Radiosensitivity in Prostate Cancer by Suppressing EIF4G1 Expression via Sponging MiR-331-3p. Cancer Cell In-ternational, 20, Article No. 449.
https://doi.org/10.1186/s12935-020-01538-8
|